Boehringer Ingelheim: Myocardial Infarction trials
The registry lists 12 Myocardial Infarction studies with Boehringer Ingelheim as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 2 1Phase 3 6Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)CompletedNCT04509674Phase 3Results posted
- STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial InfarctionCompletedNCT00623623Phase 3Results posted
- IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart AttackTerminatedNCT06139328Phase 2
- A Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®)TerminatedNCT02235389
- Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial InfarctionCompletedNCT02206646
- Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With MetalyseCompletedNCT02194153
- Observational Study of METALYSE® in Patients With Acute Myocardial Infarction In Russian FederationCompletedNCT02191670
- A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)CompletedNCT02182011Phase 3
- A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital SettingCompletedNCT02181998Phase 3
- Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)CompletedNCT02181985Phase 3
- A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)TerminatedNCT00168792Phase 4
- Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial InfarctionCompletedNCT00148460Phase 3